C12N 2770/24361
Methods of inactivation or attenuation
C12N2770/24361 (Methods of inactivation or attenuation) appears on 37 US grants and 61 published applications in this corpus.
Search patents in C12N- Granted patents
- 37
- Published applications
- 61
- Assignees
- 25
- Inventors
- 79
- Latest grant
- 25 Mar 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 2 |
| 2003 | 1 | 4 |
| 2004 | 0 | 3 |
| 2005 | 1 | 4 |
| 2006 | 2 | 2 |
| 2007 | 2 | 3 |
| 2008 | 2 | 7 |
| 2009 | 1 | 7 |
| 2010 | 2 | 5 |
| 2011 | 2 | 4 |
| 2012 | 2 | 4 |
| 2013 | 1 | 2 |
| 2014 | 6 | 3 |
| 2015 | 4 | 2 |
| 2016 | 1 | 0 |
| 2017 | 1 | 4 |
| 2018 | 2 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 0 | 1 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Subgroups
Granted patents
Recent patents
- Environmentally compatible detergents for inactivation of lipid-enveloped viruses25 Mar 2025US 12,258,540 B2Takeda Pharmaceutical Company Limited
- Method for the preparation of immunoglobulins23 Jul 2019US 10,358,462 B2Instituto Grifols, S.A.
- Recombinant classical swine fever virus (CSFV) comprising substitution in the TAV epitope of the E2 protein12 Jun 2018US 9,993,544 B2Boehringer Ingelheim Vetmedica GmbH
- BVDV vaccine30 Jan 2018US 9,878,030 B2Intervet Inc.
- Chimeric pestiviruses14 Feb 2017US 9,567,375 B2Zoetis Services LLC
- Recombinant classical swine fever virus e2 protein24 Oct 2024US 2024/0350610 A1Boehringer Ingelheim Vetmedica (China) Co., Ltd.
- Recombinant classical swine fever virus15 Jun 2023US 2023/0181710 A1
- Chemiluminescence photodynamic virus inactivation of red blood cells21 Apr 2022US 2022/0119777 A1
- Environmentally compatible detergents for inactivation of lipid-enveloped viruses4 Feb 2021US 2021/0032567 A1Baxalta Incorporated
- Pestivirus marker vaccine8 Aug 2019US 2019/0240311 A1Intervet Inc.
Most cited
By later US patents
- Nucleic acid amplification controls19US 9,120,849 B2ZeptoMetrix Corporation · 2015
- Nucleic acid amplification controls19US 9,127,048 B2ZeptoMetrix Corporation · 2015
- Safe attenuated bovine viral diarrhea viruses for use in pregnant cows9US 6,610,305 B1Boehringer Ingelheim Vetmedica GmbH · 2003
- Attenuated forms of bovine viral diarrhea virus8US 6,168,942 APfizer Inc. · 2001
- Attenuated pestiviruses7US 7,179,473 B2Boehringer Ingelheim Vetmedica GmbH · 2007